Geneseeq is a pioneering startup in the field of precision medicine, specifically focusing on cancer care. The company utilizes advanced genomic profiling technology to accelerate the process of precision cancer care. Geneseeq's services are designed to cater to a wide range of clients, including cancer patients, biopharma companies, and research partners.

The company operates in the healthcare and biotechnology market, offering a diverse range of cancer genomic testing. Geneseeq's business model revolves around providing comprehensive genomic insights to help match cancer patients with optimal treatments, including targeted therapy and immunotherapy. This is achieved by analyzing over 400 genes through their pan-cancer panel, while specific panels target individual cancer types.

Geneseeq also partners with biopharma and research partners, offering full research services, including project design and management, next-generation sequencing, quality control, and data analysis. The company has been involved in over 2000 research projects, providing high-quality genomic data to accelerate translational research, which is the process of applying findings from basic science to enhance human health and well-being.

The company generates revenue through the services it offers, including genomic testing and research services. Geneseeq prides itself on its high sequencing capacity, having sequenced over 900,000 samples to date, with a turnaround time of just five business days.

Keywords: Precision Medicine, Cancer Care, Genomic Profiling, Biopharma Partnerships, Translational Research, Genomic Testing, Targeted Therapy, Immunotherapy, Next-Generation Sequencing, High Sequencing Capacity.